{"id":11246,"date":"2019-10-04T00:00:00","date_gmt":"2019-10-04T05:00:00","guid":{"rendered":"https:\/\/myeloma.ca\/1970\/01\/01\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\/"},"modified":"2025-08-19T08:28:21","modified_gmt":"2025-08-19T13:28:21","slug":"daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve","status":"publish","type":"post","link":"https:\/\/myeloma.ca\/fr\/2019\/10\/04\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\/","title":{"rendered":"DARATUMUMAB (DARZALEX) EST MAINTENANT DISPONIBLE \u00c0 TERRE-NEUVE"},"content":{"rendered":"<p>Le 16 ao\u00fbt 2019, Darzalex a \u00e9t\u00e9 approuv\u00e9 \u00e0 Terre-Neuve, en association avec le l\u00e9nalidomide et la dexam\u00e9thasone, ou le bort\u00e9zomib et la dexam\u00e9thasone, pour le traitement des patients atteints d\u2019un my\u00e9lome multiple ayant un bon indice de performance et ayant re\u00e7u au moins un traitement ant\u00e9rieur.<\/p>\n<p><a href=\"https:\/\/www.cadth.ca\/sites\/default\/files\/pcodr\/pcodr_profund_daratumumab_darzalex_mm_2ln_beyond.pdf\" target=\"_blank\" rel=\"noopener\">Tous les d\u00e9tails<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le 16 ao\u00fbt 2019, Darzalex a \u00e9t\u00e9 approuv\u00e9 \u00e0 Terre-Neuve, en association avec le l\u00e9nalidomide et la dexam\u00e9thasone, ou le bort\u00e9zomib et la dexam\u00e9thasone, pour le traitement des patients atteints d\u2019un my\u00e9lome multiple ayant un bon indice de performance et ayant re\u00e7u au moins un traitement ant\u00e9rieur. Tous les d\u00e9tails<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[53,50,58,52],"tags":[],"class_list":["post-11246","post","type-post","status-publish","format-standard","hentry","category-actualites-et-evenement","category-news-events","category-nouvelles-de-myelome-canada","category-whats-new-at-myeloma-canada"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.0.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Le 16 ao\u00fbt 2019, Darzalex a \u00e9t\u00e9 approuv\u00e9 \u00e0 Terre-Neuve, en association avec le l\u00e9nalidomide et la dexam\u00e9thasone, ou le bort\u00e9zomib et la dexam\u00e9thasone, pour le traitement des patients atteints d\u2019un my\u00e9lome multiple ayant un bon indice de performance et ayant re\u00e7u au moins un traitement ant\u00e9rieur. Tous les d\u00e9tails\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"lemieuxbedard\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/myeloma.ca\/fr\/2019\/10\/04\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.0.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"fr_FR\" \/>\n\t\t<meta property=\"og:site_name\" content=\"My\u00e9lome Canada |\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"DARATUMUMAB (DARZALEX) EST MAINTENANT DISPONIBLE \u00c0 TERRE-NEUVE | My\u00e9lome Canada\" \/>\n\t\t<meta property=\"og:description\" content=\"Le 16 ao\u00fbt 2019, Darzalex a \u00e9t\u00e9 approuv\u00e9 \u00e0 Terre-Neuve, en association avec le l\u00e9nalidomide et la dexam\u00e9thasone, ou le bort\u00e9zomib et la dexam\u00e9thasone, pour le traitement des patients atteints d\u2019un my\u00e9lome multiple ayant un bon indice de performance et ayant re\u00e7u au moins un traitement ant\u00e9rieur. Tous les d\u00e9tails\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/myeloma.ca\/fr\/2019\/10\/04\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2019-10-04T05:00:00+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2025-08-19T13:28:21+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"DARATUMUMAB (DARZALEX) EST MAINTENANT DISPONIBLE \u00c0 TERRE-NEUVE | My\u00e9lome Canada\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Le 16 ao\u00fbt 2019, Darzalex a \u00e9t\u00e9 approuv\u00e9 \u00e0 Terre-Neuve, en association avec le l\u00e9nalidomide et la dexam\u00e9thasone, ou le bort\u00e9zomib et la dexam\u00e9thasone, pour le traitement des patients atteints d\u2019un my\u00e9lome multiple ayant un bon indice de performance et ayant re\u00e7u au moins un traitement ant\u00e9rieur. Tous les d\u00e9tails\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2019\\\/10\\\/04\\\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\\\/#blogposting\",\"name\":\"DARATUMUMAB (DARZALEX) EST MAINTENANT DISPONIBLE \\u00c0 TERRE-NEUVE | My\\u00e9lome Canada\",\"headline\":\"DARATUMUMAB (DARZALEX) EST MAINTENANT DISPONIBLE \\u00c0 TERRE-NEUVE\",\"author\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/stage.myeloma.ca\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo_en.png\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#articleImage\"},\"datePublished\":\"2019-10-04T00:00:00-05:00\",\"dateModified\":\"2025-08-19T08:28:21-05:00\",\"inLanguage\":\"fr-FR\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2019\\\/10\\\/04\\\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2019\\\/10\\\/04\\\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\\\/#webpage\"},\"articleSection\":\"Actualit\\u00e9s et \\u00e9v\\u00e9nement, News &amp; Events, Nouvelles de My\\u00e9lome Canada, What's new at Myeloma Canada, Facultatif, Optional\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2019\\\/10\\\/04\\\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#listItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/category\\\/news-events\\\/#listItem\",\"name\":\"News &amp; Events\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/category\\\/news-events\\\/#listItem\",\"position\":2,\"name\":\"News &amp; Events\",\"item\":\"https:\\\/\\\/myeloma.ca\\\/category\\\/news-events\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/category\\\/news-events\\\/whats-new-at-myeloma-canada\\\/#listItem\",\"name\":\"What's new at Myeloma Canada\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#listItem\",\"name\":\"Accueil\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/category\\\/news-events\\\/whats-new-at-myeloma-canada\\\/#listItem\",\"position\":3,\"name\":\"What's new at Myeloma Canada\",\"item\":\"https:\\\/\\\/myeloma.ca\\\/category\\\/news-events\\\/whats-new-at-myeloma-canada\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2019\\\/10\\\/04\\\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\\\/#listItem\",\"name\":\"DARATUMUMAB (DARZALEX) EST MAINTENANT DISPONIBLE \\u00c0 TERRE-NEUVE\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/category\\\/news-events\\\/#listItem\",\"name\":\"News &amp; Events\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2019\\\/10\\\/04\\\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\\\/#listItem\",\"position\":4,\"name\":\"DARATUMUMAB (DARZALEX) EST MAINTENANT DISPONIBLE \\u00c0 TERRE-NEUVE\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/category\\\/news-events\\\/whats-new-at-myeloma-canada\\\/#listItem\",\"name\":\"What's new at Myeloma Canada\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#organization\",\"name\":\"Myeloma Canada\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"telephone\":\"+18887985771\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/stage.myeloma.ca\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo_en.png\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2019\\\/10\\\/04\\\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\\\/#organizationLogo\"},\"image\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2019\\\/10\\\/04\\\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\\\/#organizationLogo\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/\",\"name\":\"lemieuxbedard\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2019\\\/10\\\/04\\\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/46bccf9afb319784ce7a4c49e51be67f2ed9bed19ab02f5f0a63c7aba8c80f06?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"lemieuxbedard\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2019\\\/10\\\/04\\\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\\\/#webpage\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2019\\\/10\\\/04\\\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\\\/\",\"name\":\"DARATUMUMAB (DARZALEX) EST MAINTENANT DISPONIBLE \\u00c0 TERRE-NEUVE | My\\u00e9lome Canada\",\"description\":\"Le 16 ao\\u00fbt 2019, Darzalex a \\u00e9t\\u00e9 approuv\\u00e9 \\u00e0 Terre-Neuve, en association avec le l\\u00e9nalidomide et la dexam\\u00e9thasone, ou le bort\\u00e9zomib et la dexam\\u00e9thasone, pour le traitement des patients atteints d\\u2019un my\\u00e9lome multiple ayant un bon indice de performance et ayant re\\u00e7u au moins un traitement ant\\u00e9rieur. Tous les d\\u00e9tails\",\"inLanguage\":\"fr-FR\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2019\\\/10\\\/04\\\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\"},\"datePublished\":\"2019-10-04T00:00:00-05:00\",\"dateModified\":\"2025-08-19T08:28:21-05:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"name\":\"Myeloma Canada\",\"inLanguage\":\"fr-FR\",\"publisher\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"DARATUMUMAB (DARZALEX) EST MAINTENANT DISPONIBLE \u00c0 TERRE-NEUVE | My\u00e9lome Canada","description":"Le 16 ao\u00fbt 2019, Darzalex a \u00e9t\u00e9 approuv\u00e9 \u00e0 Terre-Neuve, en association avec le l\u00e9nalidomide et la dexam\u00e9thasone, ou le bort\u00e9zomib et la dexam\u00e9thasone, pour le traitement des patients atteints d\u2019un my\u00e9lome multiple ayant un bon indice de performance et ayant re\u00e7u au moins un traitement ant\u00e9rieur. Tous les d\u00e9tails","canonical_url":"https:\/\/myeloma.ca\/fr\/2019\/10\/04\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/myeloma.ca\/fr\/2019\/10\/04\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\/#blogposting","name":"DARATUMUMAB (DARZALEX) EST MAINTENANT DISPONIBLE \u00c0 TERRE-NEUVE | My\u00e9lome Canada","headline":"DARATUMUMAB (DARZALEX) EST MAINTENANT DISPONIBLE \u00c0 TERRE-NEUVE","author":{"@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author"},"publisher":{"@id":"https:\/\/myeloma.ca\/fr\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/stage.myeloma.ca\/wp-content\/uploads\/2023\/02\/logo_en.png","@id":"https:\/\/myeloma.ca\/fr\/#articleImage"},"datePublished":"2019-10-04T00:00:00-05:00","dateModified":"2025-08-19T08:28:21-05:00","inLanguage":"fr-FR","mainEntityOfPage":{"@id":"https:\/\/myeloma.ca\/fr\/2019\/10\/04\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\/#webpage"},"isPartOf":{"@id":"https:\/\/myeloma.ca\/fr\/2019\/10\/04\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\/#webpage"},"articleSection":"Actualit\u00e9s et \u00e9v\u00e9nement, News &amp; Events, Nouvelles de My\u00e9lome Canada, What's new at Myeloma Canada, Facultatif, Optional"},{"@type":"BreadcrumbList","@id":"https:\/\/myeloma.ca\/fr\/2019\/10\/04\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/#listItem","position":1,"name":"Accueil","item":"https:\/\/myeloma.ca\/fr\/","nextItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/category\/news-events\/#listItem","name":"News &amp; Events"}},{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/category\/news-events\/#listItem","position":2,"name":"News &amp; Events","item":"https:\/\/myeloma.ca\/category\/news-events\/","nextItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/category\/news-events\/whats-new-at-myeloma-canada\/#listItem","name":"What's new at Myeloma Canada"},"previousItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/#listItem","name":"Accueil"}},{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/category\/news-events\/whats-new-at-myeloma-canada\/#listItem","position":3,"name":"What's new at Myeloma Canada","item":"https:\/\/myeloma.ca\/category\/news-events\/whats-new-at-myeloma-canada\/","nextItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/2019\/10\/04\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\/#listItem","name":"DARATUMUMAB (DARZALEX) EST MAINTENANT DISPONIBLE \u00c0 TERRE-NEUVE"},"previousItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/category\/news-events\/#listItem","name":"News &amp; Events"}},{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/2019\/10\/04\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\/#listItem","position":4,"name":"DARATUMUMAB (DARZALEX) EST MAINTENANT DISPONIBLE \u00c0 TERRE-NEUVE","previousItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/category\/news-events\/whats-new-at-myeloma-canada\/#listItem","name":"What's new at Myeloma Canada"}}]},{"@type":"Organization","@id":"https:\/\/myeloma.ca\/fr\/#organization","name":"Myeloma Canada","url":"https:\/\/myeloma.ca\/fr\/","telephone":"+18887985771","logo":{"@type":"ImageObject","url":"https:\/\/stage.myeloma.ca\/wp-content\/uploads\/2023\/02\/logo_en.png","@id":"https:\/\/myeloma.ca\/fr\/2019\/10\/04\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\/#organizationLogo"},"image":{"@id":"https:\/\/myeloma.ca\/fr\/2019\/10\/04\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\/#organizationLogo"}},{"@type":"Person","@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author","url":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/","name":"lemieuxbedard","image":{"@type":"ImageObject","@id":"https:\/\/myeloma.ca\/fr\/2019\/10\/04\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/46bccf9afb319784ce7a4c49e51be67f2ed9bed19ab02f5f0a63c7aba8c80f06?s=96&d=mm&r=g","width":96,"height":96,"caption":"lemieuxbedard"}},{"@type":"WebPage","@id":"https:\/\/myeloma.ca\/fr\/2019\/10\/04\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\/#webpage","url":"https:\/\/myeloma.ca\/fr\/2019\/10\/04\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\/","name":"DARATUMUMAB (DARZALEX) EST MAINTENANT DISPONIBLE \u00c0 TERRE-NEUVE | My\u00e9lome Canada","description":"Le 16 ao\u00fbt 2019, Darzalex a \u00e9t\u00e9 approuv\u00e9 \u00e0 Terre-Neuve, en association avec le l\u00e9nalidomide et la dexam\u00e9thasone, ou le bort\u00e9zomib et la dexam\u00e9thasone, pour le traitement des patients atteints d\u2019un my\u00e9lome multiple ayant un bon indice de performance et ayant re\u00e7u au moins un traitement ant\u00e9rieur. Tous les d\u00e9tails","inLanguage":"fr-FR","isPartOf":{"@id":"https:\/\/myeloma.ca\/fr\/#website"},"breadcrumb":{"@id":"https:\/\/myeloma.ca\/fr\/2019\/10\/04\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\/#breadcrumblist"},"author":{"@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author"},"creator":{"@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author"},"datePublished":"2019-10-04T00:00:00-05:00","dateModified":"2025-08-19T08:28:21-05:00"},{"@type":"WebSite","@id":"https:\/\/myeloma.ca\/fr\/#website","url":"https:\/\/myeloma.ca\/fr\/","name":"Myeloma Canada","inLanguage":"fr-FR","publisher":{"@id":"https:\/\/myeloma.ca\/fr\/#organization"}}]},"og:locale":"fr_FR","og:site_name":"My\u00e9lome Canada |","og:type":"article","og:title":"DARATUMUMAB (DARZALEX) EST MAINTENANT DISPONIBLE \u00c0 TERRE-NEUVE | My\u00e9lome Canada","og:description":"Le 16 ao\u00fbt 2019, Darzalex a \u00e9t\u00e9 approuv\u00e9 \u00e0 Terre-Neuve, en association avec le l\u00e9nalidomide et la dexam\u00e9thasone, ou le bort\u00e9zomib et la dexam\u00e9thasone, pour le traitement des patients atteints d\u2019un my\u00e9lome multiple ayant un bon indice de performance et ayant re\u00e7u au moins un traitement ant\u00e9rieur. Tous les d\u00e9tails","og:url":"https:\/\/myeloma.ca\/fr\/2019\/10\/04\/daratumumab-darzalex-est-maintenant-disponible-a-terre-neuve\/","article:published_time":"2019-10-04T05:00:00+00:00","article:modified_time":"2025-08-19T13:28:21+00:00","twitter:card":"summary_large_image","twitter:title":"DARATUMUMAB (DARZALEX) EST MAINTENANT DISPONIBLE \u00c0 TERRE-NEUVE | My\u00e9lome Canada","twitter:description":"Le 16 ao\u00fbt 2019, Darzalex a \u00e9t\u00e9 approuv\u00e9 \u00e0 Terre-Neuve, en association avec le l\u00e9nalidomide et la dexam\u00e9thasone, ou le bort\u00e9zomib et la dexam\u00e9thasone, pour le traitement des patients atteints d\u2019un my\u00e9lome multiple ayant un bon indice de performance et ayant re\u00e7u au moins un traitement ant\u00e9rieur. Tous les d\u00e9tails"},"aioseo_meta_data":{"post_id":"11246","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2023-09-18 17:04:47","updated":"2026-04-30 07:29:56","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11246","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=11246"}],"version-history":[{"count":1,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11246\/revisions"}],"predecessor-version":[{"id":31325,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11246\/revisions\/31325"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=11246"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/categories?post=11246"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=11246"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}